Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmissible agents and the surgeon

H K Lyerly

    Journal of the American College of Surgeons
    |January 1, 1995
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018
    Same author

    Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2015
    Same author

    Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.

    Cancer gene therapy·2011
    Same author

    Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.

    British journal of cancer·2011
    Same author

    ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers.

    Clinical and experimental immunology·2010
    Same author

    Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.

    British journal of cancer·2009
    Same journal

    Breaking the Polytrauma-Brain Barrier: Using Point-of-Care Biomarkers in Severely Injured Trauma Patients.

    Journal of the American College of Surgeons·2026
    Same journal

    Going the Extra Mile: Picking the Right Trauma Center Destination for Critically Injured Patients in a Mature State-Wide Trauma System.

    Journal of the American College of Surgeons·2026
    Same journal

    What Does It Mean for Surgeons to Be Flourishing?

    Journal of the American College of Surgeons·2026
    Same journal

    Tailor-Made Solution to Trimming Venous Thromboembolism Risk.

    Journal of the American College of Surgeons·2026
    Same journal

    NIH Funding in Surgical Artificial Intelligence: Who, What, Where, Why.

    Journal of the American College of Surgeons·2026
    Same journal

    Efficacy and Safety of Rezūm Water Vapor Thermal Ablation in Large and Small Prostates: A Multicenter Comparative Analysis of 2,725 Patients.

    Journal of the American College of Surgeons·2026
    See all related articles